Ekso Bionics Holdings, Inc. Quarterly report pursuant to Section 13 or 15(d)

Quarterly report pursuant to Section 13 or 15(d)

Note 7 - Revenue (Tables)

Note 7 - Revenue (Tables)

6 Months Ended

Jun. 30, 2023

Notes Tables

Contract with Customer, Contract Asset, Contract Liability, and Receivable [Table Text Block]

		*June 30, 2023*				*December 31, 2022*
Deferred extended maintenance and support		$	2,843				2,124
Customer advances			75				29
Total deferred revenues			2,918				2,153
Less current portion			(1,286	)			(1,121	)
Deferred revenues, non-current		$	1,632			$	1,032

Beginning balance		$	2,153
Deferral of revenue			2,145
Recognition of deferred revenue			(1,380	)
Ending balance		$	2,918

Disaggregation of Revenue [Table Text Block]

		*EksoHealth*				*EksoWorks*				*Total*
Device revenue		$	3,603			$	7			$	3,610
Service and support			722				—				722
Subscriptions			261				4				265
Parts and other			102				4				106
		$	4,688			$	15			$	4,703

		*EksoHealth*				*EksoWorks*				*Total*
Device revenue		$	6,651			$	118			$	6,769
Service and support			1,366				—				1,366
Subscriptions			536				11				547
Parts and other			131				12				143
		$	8,684			$	141			$	8,825

		*EksoHealth*				*EksoWorks*				*Total*
Device revenue		$	2,369			$	163			$	2,532
Service and support			489				—				489
Subscriptions			225				51				276
Parts and other			117				23				140
Collaborative arrangements			28				—				28
		$	3,228			$	237			$	3,465

		*EksoHealth*				*EksoWorks*				*Total*
Device revenue		$	3,332			$	472			$	3,804
Service and support			956				—				956
Subscriptions			441				120				561
Parts and other			273				331				604
Collaborative arrangements			107				—				107
		$	5,109			$	923			$	6,032